Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine for prevention of postoperative delirium after noncardiac surgery in older adults
NL-OMON38654Phase 3Active, not recruiting
- Sponsor
- Erasmus MC
- Start
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of esketamine in postoperative delirium (POD), sponsored by Erasmus MC. Started Jan 2014; status: active, not recruiting.
02
Drugs
esketamine
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on NL-OMON38654.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON38654.